vs
Reynolds Consumer Products Inc.（REYN）とRevvity（RVTY）の財務データ比較。上の社名をクリックして会社を切り替えられます
Reynolds Consumer Products Inc.の直近四半期売上が大きい（$1.0B vs $772.1M、Revvityの約1.3倍）。Revvityの純利益率が高く（12.7% vs 11.4%、差は1.3%）。Revvityの前年同期比売上増加率が高い（5.9% vs 1.2%）。Reynolds Consumer Products Inc.の直近四半期フリーキャッシュフローが多い（$200.0M vs $161.8M）。過去8四半期でReynolds Consumer Products Inc.の売上複合成長率が高い（11.4% vs 9.0%）
レイノルズ・コンシューマー・プロダクツ傘下のRivalは米国の小型家電メーカーで、Bionaire、クロックポット、Rivalなど多数の有名ブランドを保有しています。1999年にHolmes Productsの完全子会社となり、2005年にJardenによるHolmes買収を経て、現在はニューウェルブランズの傘下にあります。
レブィティ（Revvity, Inc.）は米国のライフサイエンス・診断事業を手がける企業で、製薬およびバイオテクノロジー業界を主な顧客とし、特に新たな細胞治療や遺伝子治療の開発に関連するサービス・製品を提供している。前身は多岐にわたる事業を展開してきた老舗企業パーキンエルマーである。
REYN vs RVTY — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.0B | $772.1M |
| 純利益 | $118.0M | $98.4M |
| 粗利率 | 25.7% | — |
| 営業利益率 | 14.8% | 14.5% |
| 純利益率 | 11.4% | 12.7% |
| 売上前年比 | 1.2% | 5.9% |
| 純利益前年比 | -1.7% | 3.9% |
| EPS（希薄化後） | $0.55 | $0.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.0B | $772.1M | ||
| Q3 25 | $931.0M | $698.9M | ||
| Q2 25 | $938.0M | $720.3M | ||
| Q1 25 | $818.0M | $664.8M | ||
| Q4 24 | $1.0B | $729.4M | ||
| Q3 24 | $910.0M | $684.0M | ||
| Q2 24 | $930.0M | $691.7M | ||
| Q1 24 | $833.0M | $649.9M |
| Q4 25 | $118.0M | $98.4M | ||
| Q3 25 | $79.0M | $46.7M | ||
| Q2 25 | $73.0M | $53.9M | ||
| Q1 25 | $31.0M | $42.2M | ||
| Q4 24 | $120.0M | $94.6M | ||
| Q3 24 | $86.0M | $94.4M | ||
| Q2 24 | $97.0M | $55.4M | ||
| Q1 24 | $49.0M | $26.0M |
| Q4 25 | 25.7% | — | ||
| Q3 25 | 25.0% | 53.6% | ||
| Q2 25 | 24.1% | 54.5% | ||
| Q1 25 | 23.1% | 56.5% | ||
| Q4 24 | 27.6% | — | ||
| Q3 24 | 26.3% | 56.3% | ||
| Q2 24 | 27.5% | 55.7% | ||
| Q1 24 | 24.1% | 54.6% |
| Q4 25 | 14.8% | 14.5% | ||
| Q3 25 | 11.0% | 11.7% | ||
| Q2 25 | 10.2% | 12.6% | ||
| Q1 25 | 5.1% | 10.9% | ||
| Q4 24 | 15.5% | 16.3% | ||
| Q3 24 | 12.4% | 14.3% | ||
| Q2 24 | 12.4% | 12.4% | ||
| Q1 24 | 7.8% | 6.8% |
| Q4 25 | 11.4% | 12.7% | ||
| Q3 25 | 8.5% | 6.7% | ||
| Q2 25 | 7.8% | 7.5% | ||
| Q1 25 | 3.8% | 6.4% | ||
| Q4 24 | 11.7% | 13.0% | ||
| Q3 24 | 9.5% | 13.8% | ||
| Q2 24 | 10.4% | 8.0% | ||
| Q1 24 | 5.9% | 4.0% |
| Q4 25 | $0.55 | $0.86 | ||
| Q3 25 | $0.38 | $0.40 | ||
| Q2 25 | $0.35 | $0.46 | ||
| Q1 25 | $0.15 | $0.35 | ||
| Q4 24 | $0.57 | $0.77 | ||
| Q3 24 | $0.41 | $0.77 | ||
| Q2 24 | $0.46 | $0.45 | ||
| Q1 24 | $0.23 | $0.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $147.0M | $919.9M |
| 総負債低いほど良い | $1.6B | — |
| 株主資本純資産 | $2.3B | $7.3B |
| 総資産 | $4.9B | $12.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.70× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $147.0M | $919.9M | ||
| Q3 25 | $53.0M | $931.4M | ||
| Q2 25 | $57.0M | $991.8M | ||
| Q1 25 | $58.0M | $1.1B | ||
| Q4 24 | $137.0M | $1.2B | ||
| Q3 24 | $96.0M | $1.2B | ||
| Q2 24 | $101.0M | $2.0B | ||
| Q1 24 | $135.0M | $1.7B |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.8B | — |
| Q4 25 | $2.3B | $7.3B | ||
| Q3 25 | $2.2B | $7.4B | ||
| Q2 25 | $2.1B | $7.6B | ||
| Q1 25 | $2.1B | $7.6B | ||
| Q4 24 | $2.1B | $7.7B | ||
| Q3 24 | $2.1B | $7.9B | ||
| Q2 24 | $2.0B | $7.9B | ||
| Q1 24 | $2.0B | $7.8B |
| Q4 25 | $4.9B | $12.2B | ||
| Q3 25 | $4.9B | $12.1B | ||
| Q2 25 | $4.9B | $12.4B | ||
| Q1 25 | $4.8B | $12.4B | ||
| Q4 24 | $4.9B | $12.4B | ||
| Q3 24 | $4.8B | $12.8B | ||
| Q2 24 | $4.9B | $13.4B | ||
| Q1 24 | $4.9B | $13.4B |
| Q4 25 | 0.70× | — | ||
| Q3 25 | 0.75× | — | ||
| Q2 25 | 0.76× | — | ||
| Q1 25 | 0.77× | — | ||
| Q4 24 | 0.79× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 0.92× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $237.0M | $182.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $200.0M | $161.8M |
| FCFマージンFCF / 売上 | 19.3% | 21.0% |
| 設備投資強度設備投資 / 売上 | 3.6% | 2.6% |
| キャッシュ転換率営業CF / 純利益 | 2.01× | 1.85× |
| 直近12ヶ月FCF直近4四半期 | $316.0M | $509.4M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $237.0M | $182.0M | ||
| Q3 25 | $93.0M | $138.5M | ||
| Q2 25 | $91.0M | $134.3M | ||
| Q1 25 | $56.0M | $128.2M | ||
| Q4 24 | $182.0M | $174.2M | ||
| Q3 24 | $124.0M | $147.9M | ||
| Q2 24 | $84.0M | $158.6M | ||
| Q1 24 | $99.0M | $147.6M |
| Q4 25 | $200.0M | $161.8M | ||
| Q3 25 | $48.0M | $120.0M | ||
| Q2 25 | $51.0M | $115.5M | ||
| Q1 25 | $17.0M | $112.2M | ||
| Q4 24 | $141.0M | $149.8M | ||
| Q3 24 | $93.0M | $125.6M | ||
| Q2 24 | $65.0M | $136.6M | ||
| Q1 24 | $70.0M | $129.7M |
| Q4 25 | 19.3% | 21.0% | ||
| Q3 25 | 5.2% | 17.2% | ||
| Q2 25 | 5.4% | 16.0% | ||
| Q1 25 | 2.1% | 16.9% | ||
| Q4 24 | 13.8% | 20.5% | ||
| Q3 24 | 10.2% | 18.4% | ||
| Q2 24 | 7.0% | 19.7% | ||
| Q1 24 | 8.4% | 20.0% |
| Q4 25 | 3.6% | 2.6% | ||
| Q3 25 | 4.8% | 2.6% | ||
| Q2 25 | 4.3% | 2.6% | ||
| Q1 25 | 4.8% | 2.4% | ||
| Q4 24 | 4.0% | 3.4% | ||
| Q3 24 | 3.4% | 3.3% | ||
| Q2 24 | 2.0% | 3.2% | ||
| Q1 24 | 3.5% | 2.7% |
| Q4 25 | 2.01× | 1.85× | ||
| Q3 25 | 1.18× | 2.97× | ||
| Q2 25 | 1.25× | 2.49× | ||
| Q1 25 | 1.81× | 3.03× | ||
| Q4 24 | 1.52× | 1.84× | ||
| Q3 24 | 1.44× | 1.57× | ||
| Q2 24 | 0.87× | 2.87× | ||
| Q1 24 | 2.02× | 5.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
REYN
| Reynolds Cooking And Baking | $397.0M | 38% |
| Hefty Waste And Storage | $247.0M | 24% |
| Tableware Products | $229.0M | 22% |
| Presto Products | $164.0M | 16% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
